Technical and Derivatives Review | November 22, 2019

For Private Circulation Only

The wait continues for record highs

Sensex (40359) / Nifty (11914)

Source: Trading View

Future outlook

Markets were a bit joyful at the opening of the week gone by and in-line with this, Nifty continued its march beyond 12000 during the mid-

week. However, once again, benchmark index looked a bit tentative at higher levels and in last couple of days, this tentativeness resulted

into a decline towards the 11900 mark. Eventually, third consecutive week ended on a flat note with nominal gains of nearly two tenths of

percent to the previous weekly close.

Due to recent price action, the weekly chart now depicts three back to back ‘Doji’ candles. This indicates some indecision at a crucial

juncture but no means we are interpreting it as a sign of caution. It seems that the market is now awaiting some trigger to clock fresh

record highs. Meanwhile, the range is confined to merely 200 points on weekly basis. Only a decisive breakout outside this range would

trigger some momentum in the market. In our sense, 11880 – 11800 would be seen as immediate base and it’s a matter of time, we would

break through this sturdy wall of 12050 – 12100 to enter an uncharted territory.

With reference to our recent articles, although benchmark index is trapped in a range, lot of individual themes are doing well since last few

days. This week, stocks from infrastructure space were kept buzzing along with ‘Pharma’ stocks which appears to have come out of the

slumber. Do watch out for such potential themes which are likely to provide better trading opportunities.

Technical and Derivatives Review | November 22, 2019

For Private Circulation Only

Pharma coming out of a slumber; poised for a strong rally

Nifty Pharma (8067)

Source: Trading View

The ‘Pharma’ sector enjoyed a strong bull run in the period of 2012 – 2015 but since then this once a favourite pocket for many, went

completely out of flavour. Barring handful of names, many stocks within this space in last few years had to undergo massive price wise as

well as time wise correction. During the month of October 2019, the Nifty Pharma index had registered a low tad above the 7000 mark

and has seen some consolidation since then. As per the Fibonacci Time Retracement Theory, October 2019 was the probable month of

trend reversal for the Nifty Pharma index and in line with this observation, we did see the index showing early signs of revival.

Now, if we look at the recent price action, the Nifty Pharma index first turned the trend from down to sideways and thus, we had seen a

consolidation phase in last one month. This consolidation has set a support base for the index and now finally the stocks within the sector

have started witnessing up moves with an increase in volumes, thus indicating probability of a turnaround in this sector after its long

underperformance. On the daily chart, the Nifty Pharma index has now given a breakout above an 'Inverted Head & Shoulders' pattern

which is a positive sign. Technically, such pattern leads to an up move in short to medium term and thus, we are quite optimistic on this

sector and expect stocks within this space to give decent returns in the near term. As far as levels are concerned, the Nifty Pharma index is

first expected to rally towards its '200 SMA' which is placed around 8350, followed by an up move towards 8650-8700 in next few months.

Thus traders are advised to look for stock specific opportunities within this space from a short as well as medium term perspective.

Amongst stock specific names, Lupin, Divis Lab, Sunpharma, Dr.Reddy are few of the marquee names which could take leadership to drive

the Pharma index towards the mentioned target areas.

Technical and Derivatives Review | November 22, 2019

For Private Circulation Only

No meaningful change in F&O date, stay long

Nifty spot closed at 11914.40 this week, against a close of 11895.45 last week. The Put-Call Ratio has decreased from 1.39 to 1.31.

The annualized Cost of Carry is positive at 0.04%. The Open Interest of Nifty Futures has decreased by 8.04%.

Derivatives View

Nifty current month future closed with a premium of 0.10 points against a premium of 47.15 points to its spot. Next month future is

trading with a premium of 43.05 points.

As far as Nifty options activities for the week are concerned, the build-up was scattered between 11900-12100 call options. On the

flip side, 11900 and 11900 put options. Maximum open interest for the monthly series now stands at 12000 call and 11400 put

option.

We had a cheerful start for the week and the follow-up buying brought index tad above the psychological mark of 12000.However,

since the last three consecutive sessions, we witnessed decent profit booking around this mark to eventually conclude the week tad

below 11950. As far as open interest activities in index futures are concerned, traders preferred unwinding few of their positions in

Nifty; whereas, BankNifty added some fresh positions. At present, 11850-11900 is an immediate support zone and the hurdle is

placed around 12000-12050. Considering the overall positions, we don’t see any sign of concern in the market and we soon expect

Nifty to rally beyond the above-mentioned hurdle.

Long Formation

Scrip

Futures

Chg (%)

Price

Chg (%)

ZEEL 47259000 50.89 352.75 21.89

DISHTV 121186900 29.08 16.05 17.15

MFSL 7098300 26.96 507.30 6.11

EQUITAS 12388100 20.22 90.90 5.64

IBULHSGFIN 34169600 14.54 235.95 17.15

Weekly change in OI

Short Formation

Scrip

Futures

Chg (%)

Price

Chg (%)

SIEMENS 2803350 40.14 1491.85 (5.19)

CESC 1300800 32.95 746.45 (1.29)

TORNTPHARM 407000 30.87 1715.30 (4.11)

CONCOR 7938477 23.79 558.85 (2.45)

ONGC 25601400 20.20 133.85 (1.51)

Technical and Derivatives Review | November 22, 2019

For Private Circulation Only

Research Team Tel: 022 - 39357600 Website: www.angelbroking.com

For Technical Queries E-mail: technicalresearch-cso@angelbroking.com

For Derivatives Queries E-mail: derivatives.desk@angelbroking.com

DISCLAIMER

Angel Broking Limited (hereinafter referred to as “Angel”) is a registered Member of National Stock Exchange of India Limited, Bombay

Stock Exchange Limited and Metropolitan Stock Exchange Limited. It is also registered as a Depository Participant with CDSL and Portfolio

Manager and Investment Adviser with SEBI. It also has registration with AMFI as a Mutual Fund Distributor. Angel Broking Limited is a

registered entity with SEBI for Research Analyst in terms of SEBI (Research Analyst) Regulations, 2014 vide registration number

INH000000164. Angel or its associates has not been debarred/ suspended by SEBI or any other regulatory authority for accessing

/dealing in securities Market. Angel or its associates/analyst has not received any compensation / managed or co-managed public

offering of securities of the company covered by Analyst during the past twelve months.

This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment

decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make

such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies

referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits and

risks of such an investment.

Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and

trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's

fundamentals. Investors are advised to refer the Fundamental and Technical Research Reports available on our website to evaluate the

contrary view, if any.

The information in this document has been printed on the basis of publicly available information, internal data and other reliable sources

believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as this document is for

general guidance only. Angel Broking Limited or any of its affiliates/ group companies shall not be in any way responsible for any loss or

damage that may arise to any person from any inadvertent error in the information contained in this report. Angel Broking Limited has

not independently verified all the information contained within this document. Accordingly, we cannot testify, nor make any

representation or warranty, express or implied, to the accuracy, contents or data contained within this document. While Angel Broking

Limited endeavors to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or

other reasons that prevent us from doing so.

This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced,

redistributed or passed on, directly or indirectly.

Neither Angel Broking Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in

connection with the use of this information.

Technical and Derivatives Team:

Sameet Chavan Chief Analyst – Technical & Derivatives sameet.chavan@angelbroking.com

Ruchit Jain Technical Analyst ruchit.jain@angelbroking.com

Rajesh Bhosale Technical Analyst rajesh.bhosle@angelbroking.com

Sneha Seth Derivatives Analyst sneha.seth@angelbroking.com